Published in AIDS Weekly, September 16th, 1996
The study is taking place at the School of Clinical Medicine and Research, University of the West Indies, Queen Elizabeth Hospital (QEH) in Bridgetown, Barbados. This clinical study was undertaken following the laboratory investigations of Dr. Shalom Z. Hirschman, Mt. Sinai Hospital, New York, New York, showing that Reticulose (PNA) inhibits the replication of HIV and stimulates the immune system to produce immuno-modulators (Gamma Interferon, IL1, & IL6).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.